[S04-1pm] T3A. Smartmaterials for future medical devices and lifescience

[S04-1pm-06] AJICAP®: Chemical site-specific conjugation technology for next-generation ADC

Invited Lecture

^○Tatsuya Okuzumi¹, Yutaka Matsuda¹, Takuya Seki¹, Kei Yamada¹, Tomohiro Fujii¹, Noriko Hatada¹, Yusuke Iwai¹, Natsuki Shikida¹, Kazutaka Shimbo¹, Brian A. Mendelsohn² (1. Ajinomoto Co., Inc., 2. Ajinomoto Bio-Pharma Services)

[Lang.] Japanese

Keywords:Antibody Drug Conjugate, Site-specific, conjugation